NIH seeks clinical trial design for HPS pulmonary fibrosis.
The National Institutes of Health (NIH) seeks a contractor to design a clinical trial for Hermansky-Pudlak Syndrome (HPS) pulmonary fibrosis. The scope includes developing a trial protocol, statistical analysis plan, and data management procedures. The contractor must have expertise in rare disease clinical trials and pulmonary fibrosis. The contract is anticipated to be a firm-fixed-price type with a period of performance of 12 months. This is a presolicitation notice; the solicitation is expected to be issued on or about August 15, 2025.